RS57455B1 - Sterilna vodena suspenzija koja sadrži ciklezonid - Google Patents

Sterilna vodena suspenzija koja sadrži ciklezonid

Info

Publication number
RS57455B1
RS57455B1 YU113404A YUP113404A RS57455B1 RS 57455 B1 RS57455 B1 RS 57455B1 YU 113404 A YU113404 A YU 113404A YU P113404 A YUP113404 A YU P113404A RS 57455 B1 RS57455 B1 RS 57455B1
Authority
RS
Serbia
Prior art keywords
ciclesonide
aqueous suspension
sterile aqueous
containing sterile
autoclave
Prior art date
Application number
YU113404A
Other languages
English (en)
Inventor
Yoshihisa Nishibe
Atsuhiro Nagano
Kazuya Takanashi
Yasuhide Uejima
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of RS113404A publication Critical patent/RS113404A/sr
Publication of RS57455B1 publication Critical patent/RS57455B1/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Ovaj pronalazak daje sterilnu vodenu suspenziju, koja sadrži ciklezonid, sterilisanu u autoklavu, pri čemu koncentracija ciklezonida, posle tretiranja u autoklavu, iznosi 95% ili više, u poređenju sa koncentracijom pre tretiranja u autoklavu. Takođe, ovaj pronalazak daje postupak za pripremanje sterilne vodene suspenzije, koja sadrži ciklezonid, koji obuhvata stupanj sterilisanja u autoklavu, vodene suspenzije koja sadrži ciklezonid.
YU113404A 2002-07-02 2003-07-02 Sterilna vodena suspenzija koja sadrži ciklezonid RS57455B1 (sr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002193399 2002-07-02
PCT/JP2003/008410 WO2004004739A1 (en) 2002-07-02 2003-07-02 Ciclesonide-containing sterile aqueous suspension

Publications (2)

Publication Number Publication Date
RS113404A RS113404A (sr) 2007-02-05
RS57455B1 true RS57455B1 (sr) 2018-09-28

Family

ID=30112281

Family Applications (1)

Application Number Title Priority Date Filing Date
YU113404A RS57455B1 (sr) 2002-07-02 2003-07-02 Sterilna vodena suspenzija koja sadrži ciklezonid

Country Status (18)

Country Link
US (2) US8182824B2 (sr)
EP (2) EP3513813A1 (sr)
JP (1) JP4559221B2 (sr)
KR (1) KR101020687B1 (sr)
CN (1) CN100366256C (sr)
AU (1) AU2003245043B2 (sr)
BR (1) BRPI0312377A8 (sr)
CA (1) CA2491724C (sr)
EA (1) EA009843B1 (sr)
HK (1) HK1080365B (sr)
HR (1) HRP20050062B1 (sr)
IL (1) IL165666A (sr)
MX (1) MXPA04012756A (sr)
NO (1) NO335022B1 (sr)
NZ (1) NZ537945A (sr)
PL (1) PL224989B1 (sr)
RS (1) RS57455B1 (sr)
WO (1) WO2004004739A1 (sr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4364486B2 (ja) * 2002-07-02 2009-11-18 帝人株式会社 無菌水性懸濁製剤
EP1572217B1 (en) * 2002-12-12 2008-08-20 Nycomed GmbH Combination medicament of r,r-formoterol and ciclesonide
PT1670482E (pt) * 2003-09-16 2014-03-12 Takeda Gmbh Utilização de ciclesonida para o tratamento de doenças respiratórias
PE20050941A1 (es) * 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
WO2005102354A1 (en) * 2004-04-20 2005-11-03 Altana Pharma Ag Use of ciclesonide for the treatment of respiratory diseases in a smoking patient
GB0410995D0 (en) 2004-05-17 2004-06-23 Norton Healthcare Ltd Heat sterilization of glucocorticosteroids
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US8679545B2 (en) * 2005-11-12 2014-03-25 The Regents Of The University Of California Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract
JP5661985B2 (ja) * 2006-12-27 2015-01-28 帝人ファーマ株式会社 無菌性水性懸濁製剤
WO2011135585A2 (en) * 2010-04-28 2011-11-03 Cadila Healthcare Limited Aqueous pharmaceutical solution of ciclesonide
WO2022231532A1 (en) * 2021-04-29 2022-11-03 Arven Ilac Sanayi Ve Ticaret Anonim Sirketi Process for the preparation of sterilized suspensions for the inhalation by nebulization

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3288679A (en) * 1966-03-23 1966-11-29 Squibb & Sons Inc Steroidal compositions and method of use
US3692430A (en) * 1971-06-18 1972-09-19 John W Timmons Liquid pumping system
US3962430A (en) 1974-08-07 1976-06-08 Merck & Co., Inc. Sterilization of solid non-electrolyte medicinal agents employing sodium chloride
SE8600632D0 (sv) 1986-02-13 1986-02-13 Kabivitrum Ab Novel pharmaceutical composition
SE9704186D0 (sv) * 1997-11-14 1997-11-14 Astra Ab New composition of matter
US6066292A (en) 1997-12-19 2000-05-23 Bayer Corporation Sterilization process for pharmaceutical suspensions
JP2001048807A (ja) 1999-08-04 2001-02-20 Wakamoto Pharmaceut Co Ltd 難溶性薬物を水に溶解してなる製剤
AR026072A1 (es) * 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica que contiene ciclesonida para aplicacion a la mucosa
CA2356177A1 (en) * 1999-10-20 2001-04-26 Kazuya Takanashi Aqueous pharmaceutical compositions
AR026073A1 (es) * 1999-10-20 2002-12-26 Nycomed Gmbh Composicion farmaceutica acuosa que contiene ciclesonida
DK1337279T3 (da) 2000-11-24 2006-09-25 Breath Ltd Sterilisation af glucocorticosteroidsuspensioner
JP4364486B2 (ja) 2002-07-02 2009-11-18 帝人株式会社 無菌水性懸濁製剤
US20040023935A1 (en) * 2002-08-02 2004-02-05 Dey, L.P. Inhalation compositions, methods of use thereof, and process for preparation of same
WO2004103379A1 (en) * 2003-05-22 2004-12-02 Altana Pharma Ag Salmeterol and ciclesonide combination

Also Published As

Publication number Publication date
HK1080365A1 (en) 2006-04-28
JP2005535656A (ja) 2005-11-24
EA200500123A1 (ru) 2005-08-25
BR0312377A (pt) 2005-04-12
JP4559221B2 (ja) 2010-10-06
PL224989B1 (pl) 2017-02-28
IL165666A (en) 2010-04-29
KR20050016706A (ko) 2005-02-21
US20100034696A1 (en) 2010-02-11
US8268240B2 (en) 2012-09-18
NO335022B1 (no) 2014-08-25
PL372940A1 (en) 2005-08-08
HRP20050062A2 (hr) 2006-04-30
EP3513813A1 (en) 2019-07-24
US8182824B2 (en) 2012-05-22
CA2491724A1 (en) 2004-01-15
NO20050529L (no) 2005-02-01
CN100366256C (zh) 2008-02-06
AU2003245043B2 (en) 2009-01-29
EP1519734A4 (en) 2011-02-23
EP1519734A1 (en) 2005-04-06
HK1080365B (zh) 2008-11-28
AU2003245043A1 (en) 2004-01-23
NZ537945A (en) 2007-08-31
MXPA04012756A (es) 2005-03-23
WO2004004739A1 (en) 2004-01-15
BRPI0312377A8 (pt) 2015-12-15
CA2491724C (en) 2013-04-02
IL165666A0 (en) 2006-01-15
RS113404A (sr) 2007-02-05
US20060166953A1 (en) 2006-07-27
CN1665517A (zh) 2005-09-07
EA009843B1 (ru) 2008-04-28
KR101020687B1 (ko) 2011-03-11
HRP20050062B1 (hr) 2013-11-08

Similar Documents

Publication Publication Date Title
NO20050529L (no) Ciclesonidinneholdende steril vandig suspensjon
ATE434590T1 (de) Verwendung eines entkeimungssystems zur entkeimung von trinkwasser
CY1115117T1 (el) Παραγωγα υποκατεστημενων οξαζολιδινονων και η χρηση τους ως αναστολεις παραγοντα χα
NO20050701L (no) 4-pyrrolidino-fenyl-benzyleter derivater
EA200300776A1 (ru) Производные фенэтаноламина для лечения респираторных заболеваний
BR0308444A (pt) Composição de vacina, método de produção de vacina, uso de uma mistura de vlps de hpv 16, hpv 18, hvp 31 e hpv 45, método de prevenção da infecção por hpv ou tratamento de doença relacionada com a infecção por hpv
DE60118743D1 (de) Methode zur behandlung und prävention von ansteckenden krankheiten
DE60112766D1 (de) Verwendung von derivaten der valproinsäureamide und 2-valproinsäureamid zur behandlung und prävention von schmerzen und/oder kopfschmerzen
EA200601091A1 (ru) Водные суспензии циклесонида для аэрозольного распыления
DE60225590D1 (de) C-kithemmer zur behandlung von bakteriellen infektionen
DE60118647D1 (de) Verwendung von Delta-Aminolevulinsäure für die Verhütung und Behandlung von Infektionen mittels pathogener Mikroorganismen und Parasiten
ATE486634T1 (de) Caspase 3, 8, 9 oder 10 inhibitoren in kombination mit mek inhibitoren zur behandlung von influenza
Huang et al. Inactivation of dengue virus by methylene blue/narrow bandwidth light system
HUP0204520A2 (en) Pharmaceutical composition containing esmolol and process for its preparation
DE60237821D1 (de) Antibakterielle behandlung von osteoarthritis
DE50111407D1 (de) Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen
DE50008908D1 (de) Verwendung einer pharmazeutischen zusammensetzung zur herstellung eines medikamentes zur behandlung von durch bakterien, viren, pilze, hefen und/oder protozoen verursachten augenerkrankungen
DE60114778D1 (de) Behandlung von infektionen in tieren
BRPI0413132A (pt) composições e compostos bicìclicos como inibidores de pdf
HUP9801925A1 (hu) Nátrium/hidrogén-csere inhibítorok alkalmazása protozoák által okozott betegségek kezelésére alkalmas gyógyszerkészítmények előállítására
SG146685A1 (en) Dihydroporphine derivatives, processes for their preparation, and pharmaceutical compositions containing them
DE602004025001D1 (de) Verbindungen zur behandlung von neuropathischen schmerzen und migräne
DE502006004735D1 (de) Mittel zur behandlung von infektionen
DE60137506D1 (de) Verwendung von polysulfatierten cyclodextrinen zur behandlung von arthrose
DE60305018D1 (de) Citalopram zur behandlung von bluthochdruck